Last reviewed · How we verify

Prednisolone acetate1%, cyclosporine 2%

Aravind Eye Care System · Phase 1 active Small molecule

Prednisolone acetate1%, cyclosporine 2% is a Small molecule drug developed by Aravind Eye Care System. It is currently in Phase 1 development. Also known as: pred forte (Prednisolone acetate1% ), aurosporine (cyclosporine 2%).

At a glance

Generic namePrednisolone acetate1%, cyclosporine 2%
Also known aspred forte (Prednisolone acetate1% ), aurosporine (cyclosporine 2%)
SponsorAravind Eye Care System
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Prednisolone acetate1%, cyclosporine 2%

What is Prednisolone acetate1%, cyclosporine 2%?

Prednisolone acetate1%, cyclosporine 2% is a Small molecule drug developed by Aravind Eye Care System.

Who makes Prednisolone acetate1%, cyclosporine 2%?

Prednisolone acetate1%, cyclosporine 2% is developed by Aravind Eye Care System (see full Aravind Eye Care System pipeline at /company/aravind-eye-care-system).

Is Prednisolone acetate1%, cyclosporine 2% also known as anything else?

Prednisolone acetate1%, cyclosporine 2% is also known as pred forte (Prednisolone acetate1% ), aurosporine (cyclosporine 2%).

What development phase is Prednisolone acetate1%, cyclosporine 2% in?

Prednisolone acetate1%, cyclosporine 2% is in Phase 1.

Related